Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

MATRISOME BIO, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

MATRISOME BIO, INC.

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: DWR8LNQUCJR8

Founded: —Source: [GOV]
Headquarters: WILMINGTON, DelawareSource: [GOV]
Headcount: 4Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

MATRISOME BIO, INC. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $1,588,234 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in WILMINGTON, Delaware.

Funding rounds

2 rounds

SBIR Phase I award (HHS)GrantJan 2025Source: [GOV]
$354.5K
—post-money
SBIR Phase II award (HHS)

Investors

No investors recorded yet for MATRISOME BIO, INC..

Add an investor

People

Leadership

DENNIS ZIMMERMANNPrincipal investigatorSince 2025Source: [GOV]

John RhodenPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

MATRISOME BIO, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for MATRISOME BIO, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Sep 2025Source: [GOV]

$1.2M

—post-money